151 related articles for article (PubMed ID: 17625938)
1. Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses.
Wilken B; Baumann M; Bien CG; Hero B; Rostasy K; Hanefeld F
Eur J Paediatr Neurol; 2008 Jan; 12(1):51-5. PubMed ID: 17625938
[TBL] [Abstract][Full Text] [Related]
2. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.
Rostásy K; Wilken B; Baumann M; Müller-Deile K; Bieber I; Gärtner J; Möller P; Angelini P; Hero B
Neuropediatrics; 2006 Oct; 37(5):291-5. PubMed ID: 17236108
[TBL] [Abstract][Full Text] [Related]
3. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
Burke MJ; Cohn SL
Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
[TBL] [Abstract][Full Text] [Related]
5. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
Chang BH; Koch T; Hopkins K; Malempati S
Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
8. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
Leen WG; Weemaes CM; Verbeek MM; Willemsen MA; Rotteveel JJ
Pediatr Neurol; 2008 Sep; 39(3):213-7. PubMed ID: 18725071
[TBL] [Abstract][Full Text] [Related]
9. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
[TBL] [Abstract][Full Text] [Related]
10. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis.
Armstrong MB; Robertson PL; Castle VP
Pediatr Neurol; 2005 Nov; 33(5):365-7. PubMed ID: 16243225
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Hoefgen ER; Swan JA; Colliver JA
Cytokine; 2008 Oct; 44(1):26-32. PubMed ID: 18675552
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
[TBL] [Abstract][Full Text] [Related]
13. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Opsoclonus-Myoclonus Syndrome in Patients of the Largest Pediatric Hospital in Latin America.
Zeny MS; do Valle DA; Santos MLSF; Bara TS; Cordeiro ML
Pediatr Neurol; 2024 May; 154():9-14. PubMed ID: 38430891
[TBL] [Abstract][Full Text] [Related]
16. [Opsoclonus-myoclonus syndrome].
Arroyo HA; Tringler N
Medicina (B Aires); 2009; 69(1 Pt 1):64-70. PubMed ID: 19240003
[TBL] [Abstract][Full Text] [Related]
17. Opsoclonus-myoclonus syndrome: a clinicopathological confrontation.
Baets J; Pals P; Bergmans B; Foncke E; Smets K; Hauman H; Vanderwegen L; Cras P
Acta Neurol Belg; 2006 Sep; 106(3):142-6. PubMed ID: 17091618
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
Blaes F; Pike MG; Lang B
J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
[TBL] [Abstract][Full Text] [Related]
19. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
[TBL] [Abstract][Full Text] [Related]
20. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
Raffaghello L; Conte M; De Grandis E; Pistoia V
Eur J Paediatr Neurol; 2009 May; 13(3):219-23. PubMed ID: 18571942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]